Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jan;12(1):166-8.
doi: 10.3201/eid1201.050930.

Neutralizing antibodies in survivors of Sin Nombre and Andes hantavirus infection

Francisca Valdivieso  1 , Pablo Vial, Marcela Ferres, Chunyan Ye, Diane Goade, Analia Cuiza, Brian Hjelle
Affiliations

Neutralizing antibodies in survivors of Sin Nombre and Andes hantavirus infection

Francisca Valdivieso et al. Emerg Infect Dis. 2006 Jan.

Abstract

We evaluated titers of homotypic and heterotypic neutralizing antibodies (NAbs) to Andes and Sin Nombre hantaviruses in plasma samples from 20 patients from Chile and the United States. All but 1 patient had high titers of NAb. None of the plasma samples showed high titers against the heterologous virus.

PubMed Disclaimer

References

    1. Monroe MC, Morzunov SP, Johnson AM, Bowen MD, Artsob H, Yates T, et al. Genetic diversity and distribution of Peromyscus-borne hantaviruses in North America. [Erratum in: Emerg Infect Dis. 1999;5:314]. Emerg Infect Dis. 1999;5:75–86. 10.3201/eid0501.990109 - DOI - PMC - PubMed
    1. Pini N. Hantavirus pulmonary syndrome in Latin America. Curr Opin Infect Dis. 2004;17:427–31. 10.1097/00001432-200410000-00007 - DOI - PubMed
    1. Severson WE, Schmaljohn CS, Javadian A, Jonsson CB. Ribavirin causes error catastrophe during Hantaan virus replication. J Virol. 2003;77:481–8. 10.1128/JVI.77.1.481-488.2003 - DOI - PMC - PubMed
    1. Huggins JW, Hsiang CM, Cosgriff TM, Guang MY, Smith JI, Wu ZO, et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis. 1991;164:1119–27. 10.1093/infdis/164.6.1119 - DOI - PubMed
    1. Mertz GJ, Miedzinski L, Goade D, Pavia AT, Hjelle B, Hansbarger CO, et al. Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis. 2004;39:1307–13. 10.1086/425007 - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources